日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Liver Cirrhosis and In-Hospital Outcomes in Patients With Sickle Cell Crises

肝硬化与镰状细胞危象患者的住院结局

Gold-Olufadi, Shakirat; Ogunniyi, Kayode; Dorcas, Adeleke Oluwaseun; Tabiti, Bukola Florence; Saparov, Dosbai; Nwachukwu, Chiamaka; Becerra, Henry; Bhavanam, Sravani; Neharika, Shrestha; Ogedegbe, John; Uche, Ifeanyi Nnamdi; Wang, Jen Chin; Emeasoba, Chinemerem Martlin; Jaamour, Dania; Awoyemi, Toluwalase

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy

双重打击和双重表达淋巴瘤:CD19靶向CAR T细胞疗法生存结果的多中心分析

Karmali, Reem; Shouse, Geoffrey; Torka, Pallawi; Moyo, Tamara K; Romancik, Jason; Barta, Stefan K; Bhansali, Rahul; Cohen, Jonathon B; Shah, Nirav N; Zurko, Joanna; Kenkre, Vaishalee P; Hess, Brian; Stephens, Deborah M; Fitzgerald, Lindsey; Ollila, Thomas; Tabiti, Bukky; Roy, Ishan; Ma, Shuo; Winter, Jane; Pro, Barbara; Moreira, Jonathan; Danilov, Alexey V; David, Kevin; Gordon, Leo I; Epperla, Narendranath

Hidden diversity and host specificity of bat trypanosomes in East and Central Africa

东非和中非蝙蝠锥虫的隐性多样性和宿主特异性

Babyesiza, Sadic Waswa; Fornůsková, Alena; Katakweba, Abdul; Kigai, Eric; Hadová, Kristýna; Ngbangui Kaguendo, Jean Luther; Bonaventure, Labo Dieu-Béni Sosthène; Tabiti, Primael; Aebischer, Thierry; de Bellocq, Joëlle Goüy; Bryja, Josef; Votýpka, Jan

Predictors of Complete Remission in Differentiated Thyroid Cancer: A Study from the Nuclear Medicine Department of Ibn Rochd Hospital in Casablanca, Morocco

分化型甲状腺癌完全缓解的预测因素:来自摩洛哥卡萨布兰卡伊本·鲁什德医院核医学科的一项研究

Tabiti, Hajar; Bendahhou, Karima; Guensi, Amal

Occurrence of Metastases in Differentiated Thyroid Carcinoma Patients: A Retrospective Study in Morrocco Covering 10 Years of Follow-Up

分化型甲状腺癌患者转移的发生情况:摩洛哥一项为期10年的回顾性研究

Tabiti, Hajar; Gbadamassi, Abdel Amide; Bendahhou, Karima; Oussafrar, Zakaria; Guensi, Amal

Determinants of Diagnosis Delay in a Sample of Breast Cancer Patients from the Mohammed VI Centre for Cancer Treatment

穆罕默德六世癌症治疗中心乳腺癌患者样本中诊断延迟的决定因素

Mohammed, Sbabou; Karima, Bendahhou; Mohamed-Yassir, Errahmani; Abdelilah, Mouafik; Hajar, Tabiti; Nadia, Tahiri Jouti

Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer

实时PCR可作为免疫组织化学方法的补充,用于确定乳腺癌中HER-2/neu的状态。

Nistor, Andreea; Watson, Peter H; Pettigrew, Norman; Tabiti, Karim; Dawson, Angelika; Myal, Yvonne